Pulmonary Hypertension News

Oral therapy CS1 could help PAH patients stay the course longer

Most PAH patients who completed one year in a CS1 expanded access program had stable or improved clinical measures.
Nasdaq

BrainStorm Announces Plans For Dosing Extension Of NurOwn - Quick Facts

(RTTNews) - BrainStorm Cell Therapeutics Inc. (BCLI) said the FDA recommended that the company submit an EAP protocol amendment to provide additional dosing of NurOwn for participants who completed ...
Nasdaq

FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program

NEW YORK, Dec. 27, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced plans for a dosing ...
ascopubs.org

Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer ...

Efficacy and quality of life (QoL) of cabazitaxel/prednisone (Cbz) in Canadian metastatic castration resistant prostate cancer (mCRPC) patients (pts) with or without ...